RTOG-0834
Terminated
Protocol Information
Tab containing protocol details, study design, and eligibility criteria
Tab containing study documents, informed consent forms, and study materials
Tab containing information for potential study participants
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma: The CATNON Intergroup Trial
Principal Investigator
Status
Terminated
Open to Accrual
July 22, 2009
Closed to Accrual
September 16, 2015
Closed to Accrual & Treatment
September 16, 2016
Terminated
August 12, 2025
Disease Site
Brain [BN] Benign Brain Tumors
Phase
III
Developmental Therapeutics
No
Patient Population
–
Target Accrual
748
Protocol Documents
Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.
-
Share this study.
-
-
-
-
